Dihydrocapsiate

• Description :

  Dihydrocapsiate, as a compound of capsinoid family, is an orally active TRPV1 agonist. Dihydrocapsiate can be used for the research of metabolism disease[1].

• UNSPSC :

  12352005

• Hazard Statement :

  H300, H315, H319, H335

• Target :

  TRP Channel

• Type :

  Natural Products

• Related Pathways :

  Membrane Transporter/Ion Channel; Neuronal Signaling

• Applications :

  Metabolism-protein/nucleotide metabolism

• Field of Research :

  Metabolic Disease

• Assay Protocol :

  https://www.medchemexpress.com/dihydrocapsiate.html

• Purity :

  99.33

• Solubility :

  DMSO : 100 mg/mL (ultrasonic)

• Smiles :

  CC(C)CCCCCCC(OCC1=CC=C(O)C(OC)=C1)=O

• Molecular Formula :

  C18H28O4

• Molecular Weight :

  308.41

• Precautions :

  H300, H315, H319, H335

• References & Citations :

  [1]Baboota RK, et al. Dihydrocapsiate supplementation prevented high-fat diet-induced adiposity, hepatic steatosis, glucose intolerance, and gut morphological alterations in mice. Nutr Res. 2018;51:40-56.

• Shipping Conditions :

  Blue Ice

• Storage Conditions :

  -20°C (Powder, protect from light)

• Scientific Category :

  Natural Products

• Clinical Information :

  Launched

• Isoform :

  TRPV1

• CAS Number :

  [205687-03-2]